巴布亚新几内亚的乙酰化表型。
Acetylator phenotypes in Papua New Guinea.
作者信息
Penketh R J, Gibney S F, Nurse G T, Hopkinson D A
出版信息
J Med Genet. 1983 Feb;20(1):37-40. doi: 10.1136/jmg.20.1.37.
Abstract
Acetylator phenotypes have been determined in 139 unrelated subjects from the hitherto untested populations of Papua New Guinea, and their relevance to current antituberculous isoniazid chemotherapy is discussed.
摘要
已在来自巴布亚新几内亚此前未经检测人群的139名无亲缘关系的受试者中确定了乙酰化表型，并讨论了其与当前抗结核异烟肼化疗的相关性。
相似文献
1
Acetylator phenotypes in Papua New Guinea.巴布亚新几内亚的乙酰化表型。
J Med Genet. 1983 Feb;20(1):37-40. doi: 10.1136/jmg.20.1.37.
2
Acetylator phenotype and short-course chemotherapy for tuberculosis in Papua New Guinea.
P N G Med J. 1989 Dec;32(4):259-62.
3
The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine.在捷克斯洛伐克使用磺胺二甲嘧啶测定结核病患者的乙酰化酶表型。
Tubercle. 1973 Mar;54(1):67-71. doi: 10.1016/0041-3879(73)90016-0.
4
Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.接受异烟肼治疗的患者中使用磺胺二甲嘧啶进行乙酰化表型分析。
Int J Clin Pharmacol Res. 1984;4(2):141-4.
5
An assessment of acetylator polymorphism and its relevance in Papua New Guinea.巴布亚新几内亚乙酰化酶多态性及其相关性评估。
P N G Med J. 1990 Jun;33(2):107-10.
6
A filter paper method for determining isoniazid acetylator phenotype.一种用于确定异烟肼乙酰化酶表型的滤纸法。
Am J Hum Genet. 1974 Jul;26(4):467-73.
7
An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitro.
Pharmacology. 1981;23(4):203-10. doi: 10.1159/000137551.
8
Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.正在接受结核病治疗患者的异烟肼乙酰化率（表型）。
Bull World Health Organ. 1971;45(5):617-24.
9
The incidence of the acetylator phenotype of isoniazid in healthy and in pulmonary tuberculosis subjects in Bihar.比哈尔邦健康人群及肺结核患者中异烟肼乙酰化表型的发生率。
J Assoc Physicians India. 1978 May;26(5):353-60.
10
Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.新型重组人N-乙酰转移酶2同工酶的催化特性和热稳定性支持慢乙酰化表型内存在基因异质性。
Arch Toxicol. 2017 Aug;91(8):2827-2835. doi: 10.1007/s00204-017-1989-7. Epub 2017 May 18.
引用本文的文献
1
Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.孕妇中磺胺多辛-乙胺嘧啶的药代动力学特性
Antimicrob Agents Chemother. 2009 Oct;53(10):4368-76. doi: 10.1128/AAC.00335-09. Epub 2009 Jul 20.
本文引用的文献
1
Peripheral neuritis due to isoniazid.异烟肼所致周围神经炎
Bull World Health Organ. 1960;23(4-5):587-98.
2
Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.人类乙酰化酶多态性：利比亚等位基因频率估计及全球分布详情。
J Med Genet. 1981 Oct;18(5):325-30. doi: 10.1136/jmg.18.5.325.
3
Blood group, red cell enzyme and serum protein types in the Buka Islanders, Papua New Guinea.巴布亚新几内亚布卡岛居民的血型、红细胞酶型和血清蛋白型
Hum Hered. 1982;32(3):152-9. doi: 10.1159/000153280.
4
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.肼屈嗪诱发的系统性红斑狼疮：HLA - DR及性别对易感性的影响。
Lancet. 1980 May 24;1(8178):1107-9. doi: 10.1016/s0140-6736(80)91554-8.
5
An improved and simplified method of detecting the acetylator phenotype.一种检测乙酰化酶表型的改良简化方法。
J Med Genet. 1969 Dec;6(4):405-7. doi: 10.1136/jmg.6.4.405.
6
Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.异烟肼乙酰化的个体和群体差异及其对肺结核治疗的意义。
Clin Pharmacol Ther. 1976 May;19(5 Pt 2):610-25. doi: 10.1002/cpt1976195part2610.
7
Clinical pharmacokinetics of isoniazid.异烟肼的临床药代动力学
Clin Pharmacokinet. 1979 Nov-Dec;4(6):401-22. doi: 10.2165/00003088-197904060-00001.
8
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.乙酰化酶表型对普鲁卡因胺诱导抗核抗体和狼疮综合征发生率的影响。
N Engl J Med. 1978 May 25;298(21):1157-9. doi: 10.1056/NEJM197805252982101.
Zotero 插件